Safety Data Highlighting Low Rates of Adverse Events and Non-Relapse Transplant Related ...

Retrieved on: 2021-06-15 12:45:00

Tags for this article:

Click the tags to see associated articles and topics

Safety Data Highlighting Low Rates of Adverse Events and Non-Relapse Transplant Related .... View article details on hiswai:

Excerpt

Via the monoclonal antibody apamistamab, Iomab-B targets CD45, an antigen widely expressed on leukemia and lymphoma cancer cells, immune ...

Article found on: www.kpvi.com